App ComparisonMedAdvisor Alternative in Australia: Compare MediRemind and Pharmacy Apps
Australian-owned and built in Perth. Manage eScripts, paper scripts, repeats and family medications — with your health data kept on your device.
Last reviewed July 2026 · General information only, not medical advice
30-day free trial · Works with any Australian pharmacy
No parent company. No overseas owner. No acquisition.
We reviewed publicly available app descriptions, App Store listings, privacy policies, ASX announcements and Australian electronic-prescription guidance to prepare this comparison. Features and policies may change. Last reviewed July 2026. This guide is published by MediRemind — we have noted where information about other apps is based on our interpretation of public materials, and we encourage readers to verify directly with each app.
Looking for a MedAdvisor alternative in Australia? MediRemind and MedAdvisor are both used by Australians, but they were built on different commercial models and store your data in fundamentally different ways.
MedAdvisor is a pharmacy platform. It connects patients to their pharmacy, enables digital prescription management through that pharmacy, and is funded by pharmacies subscribing to the platform. MediRemind is funded directly by patients.
And as of July 2025, those two apps are also owned by very different kinds of company. This guide covers both dimensions: the business model and the ownership.
The Business Model and Ownership Difference
Two things shape what a medication app does for you: who funds it, and who owns it.
Pharmacy-funded apps are built on the premise that pharmacies are commercial customers. The pharmacy pays a subscription to participate — in Australia, around $209 per month per pharmacy. Patient access is free. Pharmacy-funded platforms commonly prioritise pharmacy integration, direct ordering, dispensing history and loyalty features. MediRemind uses a patient-subscription model instead, focusing on personal medication organisation, family management and privacy-first storage.
MediRemind operates on a patient-subscription model. The patient pays $4.99 per month after a one-month free trial. Because the patient is the direct customer, features focus on personal medication organisation, family management and privacy-first data storage.
The second dimension is ownership. MediRemind is owned by an Australian family in Perth — the same team that built it. There is no parent company, no overseas investor and no acquisition.
In July 2025, the Australia and New Zealand operations of Australia's most widely used pharmacy medication app were acquired by Jonas Software ANZ — a subsidiary of Constellation Software Inc., listed on the Toronto Stock Exchange in Canada. This is confirmed via ASX market announcement dated July 2025. Patients who downloaded the app earlier may not be aware that its ownership has changed.
Feature Comparison
| Feature | MediRemind Scripts | Pharmacy-funded apps | Notes |
|---|---|---|---|
| Company ownershipNEW | Australian-owned — Ovara Tech, Perth WA, ABN 43 324 331 038. Australian family business. | Varies by app. Australia's most widely used pharmacy app was acquired by Jonas Software ANZ (subsidiary of Constellation Software Inc., Toronto Stock Exchange) in July 2025. Source: ASX announcement. | Verifiable via ASX announcements. |
| Who funds the service | User subscription — $4.99/month personal, $9.99/month family. | Pharmacy subscription. Pharmacies pay to participate; patient access is free but the pharmacy is the paying customer. | Different funding models can lead to different feature priorities. |
| Health data storage | Your medication data stays on your device. MediRemind does not upload your medication or eScript data to its servers. | Varies by app. | Critical if you care about data sovereignty. |
| Must I select a pharmacy? | No — works at any pharmacy equipped to dispense Australian eScripts. | Depends on the app — some full features require pharmacy participation. | Check whether your preferred pharmacy is supported. |
| Offline eScript display | Yes — token stored on device, displays offline at the pharmacy counter. | Depends — some apps require server connectivity at point of dispensing. | Relevant for poor signal areas, hospitals, basements. |
| Paper prescription storage | Yes — photograph paper scripts, stored locally alongside eScripts. | Depends on the app. | Some patients manage both paper and electronic prescriptions. |
| Family profiles | Up to 5 isolated profiles. One device, biometrically locked. No pharmacy account required per person. | Depends — some require individual accounts or pharmacy links per family member. | Important for carers managing elderly parents. |
| Account required to start? | Quick email sign-up only — no pharmacy account or approval required. | Depends — some require account creation and pharmacy approval first. | |
| Repeat tracking | Visual countdown, run-out alerts, manual update after each fill. | Some apps pull real-time repeat data from pharmacy dispensing systems. | Real-time sync can be more accurate than manual tracking. |
| PBS Safety Net tracking | Manual — PBS calculator included but no automatic Medicare sync. | Some apps link to Express Plus Medicare for real-time Safety Net balance. | Supplement MediRemind with the free Express Plus Medicare app. |
| Elderly-friendly interface | Designed for older Australians — simple layout, large QR display, Face ID. | Varies by app. |
Feature information for other apps is based on publicly available materials as of July 2026. Always verify directly with each app.
Who Should Use Which
MediRemind and a pharmacy app coexist without conflict. Use MediRemind for privacy-first tracking and family management, and a pharmacy app for direct reordering and Safety Net tracking.
What Pharmacy Apps Do Better
This is a fair guide — which means being honest about where pharmacy-funded apps have genuine advantages:
These are real, useful features. If your regular pharmacy participates and you are comfortable with the pharmacy-linked data model, those apps serve that use case well.
Australian-owned. Built in Perth. Your data stays on your phone.
30-day free trial · Cancel anytime
Frequently Asked Questions
Yes. MediRemind Scripts is built and owned by Ovara Tech, an Australian family business registered in Nedlands, Western Australia (ABN 43 324 331 038). The app was built by a Perth father and son for their wife and mother, who manages multiple chronic medications. All subscription revenue stays with an Australian family business. There is no parent company, no overseas investor and no acquisition in the background.
MediRemind offers a one-month free trial with After the trial, a subscription applies: $4.99 per month (personal) or $9.99 per month (family, up to 5 profiles). There are no ads and no pharmacy partnerships — the subscription is the only revenue source.
Yes. MediRemind is not tied to any pharmacy network. It stores the standard Australian eScript QR code on your device, which you present at any pharmacy equipped to dispense Australian electronic prescriptions — Chemist Warehouse, Priceline, your local independent or any other. No partner pharmacy arrangement is required.
MediRemind stores medication and eScript data locally on your device. No health data is transmitted to MediRemind servers. If you delete the app, all medication data is gone. Pharmacy-linked apps may process dispensing information through their servers to enable features such as refill reminders and ordering — check individual privacy policies for details.
Yes. They serve different purposes and coexist without conflict. Some Australians use MediRemind for privacy-first tracking, offline QR display and family management, while using a pharmacy app for direct reordering and PBS Safety Net tracking through a Medicare link.
As of July 2025, the Australia and New Zealand operations of Australia's most widely used pharmacy medication app were acquired by Jonas Software ANZ — a subsidiary of Constellation Software Inc., a company listed on the Toronto Stock Exchange in Canada. This is confirmed via ASX market announcement dated July 2025.
Legal disclaimer: This comparison is prepared by MediRemind (Ovara Tech, ABN 43 324 331 038). Information about other companies and apps is based on publicly available sources including App Store listings, websites, privacy policies and ASX market announcements as reviewed in July 2026. The acquisition referenced in the comparison table is confirmed via ASX market announcement dated July 2025 and Jonas Software press release. Features and data practices may change. We encourage readers to verify all information directly with each app.